Advanced Search (OLGA)

Gene: FAM171B (family with sequence similarity 171 member B) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

FAM171B

Name:

family with sequence similarity 171 member B

RGD ID:

1354368

HGNC Page

HGNC:29412

Description:

Predicted to be located in membrane. Predicted to be active in synapse.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

family with sequence similarity 171, member B; FLJ34104; KIAA1946

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	2	186,694,060 - 186,765,959 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	2	186,694,060 - 186,765,959 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	2	187,558,787 - 187,630,686 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	2	187,267,034 - 187,336,759 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	2	187,384,294 - 187,454,016	NCBI
Celera	2	181,154,411 - 181,224,139 (+)	NCBI		Celera
Cytogenetic Map	2	q32.1	NCBI
HuRef	2	179,418,653 - 179,488,386 (+)	NCBI		HuRef
CHM1_1	2	187,564,785 - 187,634,506 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	2	187,183,195 - 187,255,094 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM171B	Human	Neurodevelopmental Disorders		IAGP	RGD:14698794	8554872	ClinVar Annotator: match by term: Neurodevelopmental disorder	ClinVar	PMID:25741868

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM171B	Human	1,2-dichloroethane	decreases expression	ISO	RGD:1615649	6480464	ethylene dichloride results in decreased expression of FAM171B mRNA	CTD	PMID:28189721\|PMID:28960355
FAM171B	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with Progesterone] results in increased expression of FAM171B mRNA; [Raloxifene Hydrochloride co-treated with more ...	CTD	PMID:20660070\|PMID:21185374
FAM171B	Human	17beta-estradiol	decreases expression	EXP		6480464	Estradiol results in decreased expression of FAM171B mRNA	CTD	PMID:31614463
FAM171B	Human	17beta-estradiol	multiple interactions	ISO	RGD:1562526	6480464	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA	CTD	PMID:32741896
FAM171B	Human	17beta-estradiol	increases expression	ISO	RGD:1615649	6480464	Estradiol results in increased expression of FAM171B mRNA	CTD	PMID:19484750\|PMID:39298647
FAM171B	Human	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1562526	6480464	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA	CTD	PMID:32741896
FAM171B	Human	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1615649	6480464	2,2',4,4'-tetrabromodiphenyl ether affects the expression of FAM171B mRNA	CTD	PMID:30294300
FAM171B	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615649	6480464	Tetrachlorodibenzodioxin affects the expression of FAM171B mRNA	CTD	PMID:21570461\|PMID:24680724
FAM171B	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1562526	6480464	Tetrachlorodibenzodioxin results in increased expression of FAM171B mRNA	CTD	PMID:32109520
FAM171B	Human	2-hydroxypropanoic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of FAM171B mRNA	CTD	PMID:30851411
FAM171B	Human	3,3',5-triiodo-L-thyronine	decreases expression	EXP		6480464	Triiodothyronine results in decreased expression of FAM171B mRNA	CTD	PMID:23397585
FAM171B	Human	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1615649	6480464	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FAM171B mRNA	CTD	PMID:20188158
FAM171B	Human	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
FAM171B	Human	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1615649	6480464	bisphenol S results in increased expression of FAM171B mRNA	CTD	PMID:39298647
FAM171B	Human	aflatoxin B1	decreases expression	ISO	RGD:1615649	6480464	Aflatoxin B1 results in decreased expression of FAM171B mRNA	CTD	PMID:19770486
FAM171B	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of FAM171B intron	CTD	PMID:30157460
FAM171B	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of FAM171B gene	CTD	PMID:27153756
FAM171B	Human	arsane	affects methylation	EXP		6480464	Arsenic affects the methylation of FAM171B gene	CTD	PMID:25304211
FAM171B	Human	arsenic atom	affects methylation	EXP		6480464	Arsenic affects the methylation of FAM171B gene	CTD	PMID:25304211
FAM171B	Human	arsenite(3-)	decreases expression	EXP		6480464	arsenite results in decreased expression of FAM171B mRNA	CTD	PMID:23974009
FAM171B	Human	benzo[a]pyrene	decreases expression	ISO	RGD:1615649	6480464	Benzo(a)pyrene results in decreased expression of FAM171B mRNA	CTD	PMID:19770486
FAM171B	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of FAM171B promoter	CTD	PMID:27901495
FAM171B	Human	bisphenol A	decreases expression	ISO	RGD:1562526	6480464	bisphenol A results in decreased expression of FAM171B mRNA	CTD	PMID:25181051
FAM171B	Human	bisphenol A	increases expression	EXP		6480464	bisphenol A results in increased expression of FAM171B mRNA	CTD	PMID:29275510
FAM171B	Human	bisphenol A	increases expression	ISO	RGD:1562526	6480464	bisphenol A results in increased expression of FAM171B mRNA	CTD	PMID:30816183
FAM171B	Human	bisphenol F	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
FAM171B	Human	cadmium dichloride	decreases expression	EXP		6480464	Cadmium Chloride results in decreased expression of FAM171B mRNA	CTD	PMID:38382870
FAM171B	Human	cantharidin	increases expression	ISO	RGD:1615649	6480464	Cantharidin results in increased expression of FAM171B mRNA	CTD	PMID:36907384
FAM171B	Human	chlorpyrifos	decreases expression	ISO	RGD:1615649	6480464	Chlorpyrifos results in decreased expression of FAM171B mRNA	CTD	PMID:37019170
FAM171B	Human	cisplatin	multiple interactions	EXP		6480464	[Cisplatin co-treated with jinfukang] results in increased expression of FAM171B mRNA	CTD	PMID:27392435
FAM171B	Human	cisplatin	increases expression	EXP		6480464	Cisplatin results in increased expression of FAM171B mRNA	CTD	PMID:27392435
FAM171B	Human	coumestrol	multiple interactions	EXP		6480464	[Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA	CTD	PMID:19167446
FAM171B	Human	cyclosporin A	increases expression	EXP		6480464	Cyclosporine results in increased expression of FAM171B mRNA	CTD	PMID:20106945
FAM171B	Human	DDT	decreases expression	ISO	RGD:1562526	6480464	DDT results in decreased expression of FAM171B mRNA	CTD	PMID:30207508
FAM171B	Human	dexamethasone	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
FAM171B	Human	dichloroacetic acid	decreases expression	ISO	RGD:1615649	6480464	Dichloroacetic Acid results in decreased expression of FAM171B mRNA	CTD	PMID:28962523
FAM171B	Human	diuron	decreases expression	ISO	RGD:1562526	6480464	Diuron results in decreased expression of FAM171B mRNA	CTD	PMID:25152437
FAM171B	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
FAM171B	Human	epoxiconazole	decreases expression	ISO	RGD:1615649	6480464	epoxiconazole results in decreased expression of FAM171B mRNA	CTD	PMID:35436446
FAM171B	Human	ethanol	increases expression	ISO	RGD:1615649	6480464	Ethanol results in increased expression of FAM171B mRNA	CTD	PMID:30319688
FAM171B	Human	FR900359	increases phosphorylation	EXP		6480464	FR900359 results in increased phosphorylation of FAM171B protein	CTD	PMID:37730182
FAM171B	Human	gentamycin	increases expression	ISO	RGD:1562526	6480464	Gentamicins results in increased expression of FAM171B mRNA	CTD	PMID:33387578
FAM171B	Human	hydrogen peroxide	multiple interactions	EXP		6480464	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FAM171B protein	CTD	PMID:18951874
FAM171B	Human	indometacin	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
FAM171B	Human	lead(0)	affects splicing	EXP		6480464	Lead affects the splicing of FAM171B mRNA	CTD	PMID:28903495
FAM171B	Human	lead(0)	affects expression	EXP		6480464	Lead affects the expression of FAM171B mRNA	CTD	PMID:28903495
FAM171B	Human	manganese(II) chloride	increases expression	ISO	RGD:1562526	6480464	manganese chloride results in increased expression of FAM171B mRNA	CTD	PMID:28801915
FAM171B	Human	methylisothiazolinone	increases expression	EXP		6480464	2-methyl-4-isothiazolin-3-one results in increased expression of FAM171B mRNA	CTD	PMID:31629900
FAM171B	Human	N-methyl-4-phenylpyridinium	decreases expression	EXP		6480464	1-Methyl-4-phenylpyridinium results in decreased expression of FAM171B mRNA	CTD	PMID:24810058
FAM171B	Human	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1562526	6480464	1-Methyl-4-phenylpyridinium results in increased expression of FAM171B mRNA	CTD	PMID:28801915
FAM171B	Human	nickel sulfate	increases expression	EXP		6480464	nickel sulfate results in increased expression of FAM171B mRNA	CTD	PMID:22714537
FAM171B	Human	okadaic acid	increases expression	EXP		6480464	Okadaic Acid results in increased expression of FAM171B mRNA	CTD	PMID:38832940
FAM171B	Human	ozone	multiple interactions	ISO	RGD:1615649	6480464	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FAM171B more ...	CTD	PMID:27106289
FAM171B	Human	paracetamol	increases expression	ISO	RGD:1562526	6480464	Acetaminophen results in increased expression of FAM171B mRNA	CTD	PMID:33387578
FAM171B	Human	pioglitazone	multiple interactions	ISO	RGD:1615649	6480464	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FAM171B mRNA	CTD	PMID:27935865
FAM171B	Human	potassium chromate	increases expression	EXP		6480464	potassium chromate(VI) results in increased expression of FAM171B mRNA	CTD	PMID:22714537
FAM171B	Human	progesterone	multiple interactions	EXP		6480464	[Estradiol co-treated with Progesterone] results in increased expression of FAM171B mRNA	CTD	PMID:20660070
FAM171B	Human	propiconazole	decreases expression	ISO	RGD:1615649	6480464	propiconazole results in decreased expression of FAM171B mRNA	CTD	PMID:21278054
FAM171B	Human	rac-lactic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of FAM171B mRNA	CTD	PMID:30851411
FAM171B	Human	raloxifene	multiple interactions	EXP		6480464	[Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of FAM171B mRNA	CTD	PMID:21185374
FAM171B	Human	resveratrol	multiple interactions	EXP		6480464	[Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA	CTD	PMID:19167446
FAM171B	Human	rotenone	decreases expression	EXP		6480464	Rotenone results in decreased expression of FAM171B mRNA	CTD	PMID:29955902
FAM171B	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
FAM171B	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of FAM171B mRNA	CTD	PMID:22714537\|PMID:38568856
FAM171B	Human	tamoxifen	increases expression	ISO	RGD:1615649	6480464	Tamoxifen results in increased expression of FAM171B mRNA	CTD	PMID:25123088
FAM171B	Human	testosterone	multiple interactions	ISO	RGD:1562526	6480464	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA	CTD	PMID:32741896
FAM171B	Human	tetrachloromethane	increases expression	ISO	RGD:1615649	6480464	Carbon Tetrachloride results in increased expression of FAM171B mRNA	CTD	PMID:27339419\|PMID:31919559
FAM171B	Human	theophylline	multiple interactions	EXP		6480464	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FAM171B protein	CTD	PMID:18951874
FAM171B	Human	thioacetamide	decreases expression	ISO	RGD:1562526	6480464	Thioacetamide results in decreased expression of FAM171B mRNA	CTD	PMID:34492290
FAM171B	Human	titanium dioxide	decreases expression	ISO	RGD:1615649	6480464	titanium dioxide results in decreased expression of FAM171B mRNA	CTD	PMID:29264374
FAM171B	Human	Tributyltin oxide	increases expression	ISO	RGD:1615649	6480464	bis(tri-n-butyltin)oxide results in increased expression of FAM171B mRNA	CTD	PMID:25270620
FAM171B	Human	trichloroethene	increases expression	ISO	RGD:1562526	6480464	Trichloroethylene results in increased expression of FAM171B mRNA	CTD	PMID:33387578
FAM171B	Human	trichostatin A	decreases expression	EXP		6480464	trichostatin A results in decreased expression of FAM171B mRNA	CTD	PMID:24935251\|PMID:26272509
FAM171B	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
FAM171B	Human	trovafloxacin	decreases expression	ISO	RGD:1615649	6480464	trovafloxacin results in decreased expression of FAM171B mRNA	CTD	PMID:35537566
FAM171B	Human	urethane	increases expression	EXP		6480464	Urethane results in increased expression of FAM171B mRNA	CTD	PMID:28818685
FAM171B	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of FAM171B mRNA	CTD	PMID:19101580\|PMID:23179753\|PMID:27188386\|PMID:28001369
FAM171B	Human	vincristine	decreases expression	EXP		6480464	Vincristine results in decreased expression of FAM171B mRNA	CTD	PMID:23649840
FAM171B	Human	zoledronic acid	decreases expression	EXP		6480464	zoledronic acid results in decreased expression of FAM171B mRNA	CTD	PMID:24714768

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
FAM171B	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
FAM171B	Human	membrane	located_in	IEA	UniProtKB-SubCell:SL-0162	150520179		UniProt	GO_REF:0000044
FAM171B	Human	synapse	is_active_in	IEA	UniProtKB:Q14CH0\|ensembl:ENSMUSP00000062702	150520179		Ensembl	GO_REF:0000107

#	Reference Title	Reference Citation
1.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
2.	Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.	Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.

PMID:11853319	PMID:14702039	PMID:21988832	PMID:25468996	PMID:26638075	PMID:27880917	PMID:28514442	PMID:30861353	PMID:31871319	PMID:33961781	PMID:34052262	PMID:34079125
PMID:34273398	PMID:34702444	PMID:35384245	PMID:35844135	PMID:36976175	PMID:37478010	PMID:37689310	PMID:37915048	PMID:38117590	PMID:39349928

FAM171B
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	2	186,694,060 - 186,765,959 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	2	186,694,060 - 186,765,959 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	2	187,558,787 - 187,630,686 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	2	187,267,034 - 187,336,759 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	2	187,384,294 - 187,454,016	NCBI
Celera	2	181,154,411 - 181,224,139 (+)	NCBI		Celera
Cytogenetic Map	2	q32.1	NCBI
HuRef	2	179,418,653 - 179,488,386 (+)	NCBI		HuRef
CHM1_1	2	187,564,785 - 187,634,506 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	2	187,183,195 - 187,255,094 (+)	NCBI		T2T-CHM13v2.0

Fam171b
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	2	83,642,889 - 83,713,878 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	2	83,642,980 - 83,713,830 (+)	Ensembl		GRCm39 Ensembl
GRCm38	2	83,812,563 - 83,883,534 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	2	83,812,636 - 83,883,486 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	2	83,652,885 - 83,721,515 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	2	83,613,567 - 83,682,197 (+)	NCBI		MGSCv36	mm8
MGSCv36	2	84,723,794 - 84,798,606 (+)	NCBI		MGSCv36	mm8
Celera	2	85,461,824 - 85,536,326 (+)	NCBI		Celera
Cytogenetic Map	2	D	NCBI
cM Map	2	49.33	NCBI

Fam171b
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	3	89,337,566 - 89,392,973 (+)	NCBI		GRCr8
mRatBN7.2	3	68,930,755 - 68,986,113 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	3	68,930,822 - 68,986,127 (+)	Ensembl		mRatBN7.2 Ensembl
Rnor_6.0	3	71,210,048 - 71,265,419 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	3	71,210,301 - 71,262,615 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	3	77,735,454 - 77,790,821 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	3	67,037,142 - 67,092,329 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	3	68,301,422 - 68,356,773 (+)	NCBI		Celera
Cytogenetic Map	3	q24	NCBI

Fam171b
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955403	11,509,969 - 11,532,616 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955403	11,512,731 - 11,532,550 (-)	NCBI	ChiLan1.0	ChiLan1.0

FAM171B
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	13	89,372,526 - 89,445,428 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	2B	89,387,518 - 89,460,408 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	2B	73,985,579 - 74,058,803 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	2B	191,784,554 - 191,859,440 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	2B	191,786,078 - 191,859,440 (+)	Ensembl	panpan1.1		panPan2

FAM171B
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	36	28,934,725 - 28,961,613 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	36	28,905,006 - 28,961,832 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	36	28,801,621 - 28,860,554 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	36	29,128,551 - 29,188,402 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	36	29,128,551 - 29,188,377 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	36	29,185,301 - 29,245,138 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	36	29,120,471 - 29,180,586 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	36	29,288,267 - 29,348,107 (+)	NCBI		UU_Cfam_GSD_1.0

Fam171b
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405303	146,106,419 - 146,177,805 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936506	10,660,196 - 10,731,659 (-)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936506	10,662,513 - 10,731,653 (-)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

FAM171B
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	15	91,719,511 - 91,798,010 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	15	91,724,228 - 91,798,012 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	15	101,733,215 - 101,806,942 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

FAM171B
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	10	72,229,785 - 72,301,767 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	10	72,229,841 - 72,301,902 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666040	127,204,559 - 127,276,880 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Fam171b
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla 1.0	NW_004624899	3,157,724 - 3,189,847 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in FAM171B
51 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 2q31.1-33.2(chr2:174898848-203941548)x1	copy number loss	See cases [RCV000050980]	Chr2:174898848..203941548 [GRCh38] Chr2:175763576..204806271 [GRCh37] Chr2:175471822..204514516 [NCBI36] Chr2:2q31.1-33.2	pathogenic
GRCh38/hg38 2q31.1-33.1(chr2:176304445-202039790)x1	copy number loss	See cases [RCV000052558]	Chr2:176304445..202039790 [GRCh38] Chr2:177169173..202904513 [GRCh37] Chr2:176877419..202612758 [NCBI36] Chr2:2q31.1-33.1	pathogenic
GRCh38/hg38 2q31.2-33.1(chr2:177874070-198525492)x1	copy number loss	See cases [RCV000052559]	Chr2:177874070..198525492 [GRCh38] Chr2:178738797..199390216 [GRCh37] Chr2:178447043..199098461 [NCBI36] Chr2:2q31.2-33.1	pathogenic
GRCh38/hg38 2q32.1-33.1(chr2:186027472-201059372)x1	copy number loss	See cases [RCV000135876]	Chr2:186027472..201059372 [GRCh38] Chr2:186892199..201924095 [GRCh37] Chr2:186600444..201632340 [NCBI36] Chr2:2q32.1-33.1	pathogenic
GRCh38/hg38 2q31.1-32.2(chr2:171429233-189179568)x1	copy number loss	See cases [RCV000136850]	Chr2:171429233..189179568 [GRCh38] Chr2:172285743..190044294 [GRCh37] Chr2:171993989..189752539 [NCBI36] Chr2:2q31.1-32.2	pathogenic
GRCh38/hg38 2q31.1-32.2(chr2:174634502-189000964)x1	copy number loss	See cases [RCV000136861]	Chr2:174634502..189000964 [GRCh38] Chr2:175499230..189865690 [GRCh37] Chr2:175207476..189573935 [NCBI36] Chr2:2q31.1-32.2	pathogenic
GRCh38/hg38 2q31.3-32.1(chr2:180942902-187372388)x1	copy number loss	See cases [RCV000137116]	Chr2:180942902..187372388 [GRCh38] Chr2:181807629..188237115 [GRCh37] Chr2:181515874..187945360 [NCBI36] Chr2:2q31.3-32.1	pathogenic
GRCh38/hg38 2q31.3-32.3(chr2:181758701-192015392)x1	copy number loss	See cases [RCV000138253]	Chr2:181758701..192015392 [GRCh38] Chr2:182623428..192880118 [GRCh37] Chr2:182331673..192588363 [NCBI36] Chr2:2q31.3-32.3	pathogenic
GRCh38/hg38 2q31.3-36.2(chr2:180513793-224302848)x3	copy number gain	See cases [RCV000139446]	Chr2:180513793..224302848 [GRCh38] Chr2:181378520..225167565 [GRCh37] Chr2:181086765..224875809 [NCBI36] Chr2:2q31.3-36.2	pathogenic
GRCh38/hg38 2q31.2-32.3(chr2:177827730-195125329)x1	copy number loss	See cases [RCV000141735]	Chr2:177827730..195125329 [GRCh38] Chr2:178692457..195990053 [GRCh37] Chr2:178400703..195698298 [NCBI36] Chr2:2q31.2-32.3	pathogenic
GRCh38/hg38 2q31.1-32.3(chr2:176086763-193201970)x1	copy number loss	See cases [RCV000143484]	Chr2:176086763..193201970 [GRCh38] Chr2:176951491..194066696 [GRCh37] Chr2:176659737..193774941 [NCBI36] Chr2:2q31.1-32.3	pathogenic
GRCh37/hg19 2q31.1-32.3(chr2:177315153-196375520)x1	copy number loss	See cases [RCV000239432]	Chr2:177315153..196375520 [GRCh37] Chr2:2q31.1-32.3	pathogenic
GRCh37/hg19 2q31.1-35(chr2:169829974-215521436)x3	copy number gain	See cases [RCV000448271]	Chr2:169829974..215521436 [GRCh37] Chr2:2q31.1-35	pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)	copy number gain	See cases [RCV000512056]	Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3	pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3	copy number gain	See cases [RCV000511212]	Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3	pathogenic
NM_177454.4(FAM171B):c.1391A>G (p.Asn464Ser)	single nucleotide variant	not specified [RCV004303377]	Chr2:186761733 [GRCh38] Chr2:187626460 [GRCh37] Chr2:2q32.1	uncertain significance
GRCh37/hg19 2p25.3-q37.3(chr2:15672-243101834)x3	copy number gain	not provided [RCV000752804]	Chr2:15672..243101834 [GRCh37] Chr2:2p25.3-q37.3	pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:14238-243048760)x3	copy number gain	not provided [RCV000752802]	Chr2:14238..243048760 [GRCh37] Chr2:2p25.3-q37.3	pathogenic
GRCh37/hg19 2q32.1(chr2:187370142-188535099)x4	copy number gain	not provided [RCV000740779]	Chr2:187370142..188535099 [GRCh37] Chr2:2q32.1	uncertain significance
GRCh37/hg19 2q32.1(chr2:187440683-187625351)x3	copy number gain	not provided [RCV000740780]	Chr2:187440683..187625351 [GRCh37] Chr2:2q32.1	benign
NM_177454.4(FAM171B):c.147G>A (p.Gln49=)	single nucleotide variant	not provided [RCV000883680]	Chr2:186694320 [GRCh38] Chr2:187559047 [GRCh37] Chr2:2q32.1	benign
NM_177454.4(FAM171B):c.330G>A (p.Thr110=)	single nucleotide variant	not provided [RCV000885133]	Chr2:186740319 [GRCh38] Chr2:187605046 [GRCh37] Chr2:2q32.1	benign
Single allele	deletion	Neurodevelopmental disorder [RCV000787402]	Chr2:186356601..188906835 [GRCh37] Chr2:2q32.1	pathogenic
GRCh37/hg19 2q24.3-32.3(chr2:167329586-192756373)x1	copy number loss	not provided [RCV000848216]	Chr2:167329586..192756373 [GRCh37] Chr2:2q24.3-32.3	pathogenic
GRCh37/hg19 2q32.1(chr2:186861444-188658263)x1	copy number loss	not provided [RCV000845864]	Chr2:186861444..188658263 [GRCh37] Chr2:2q32.1	uncertain significance
GRCh37/hg19 2q32.1(chr2:187445266-187627894)x3	copy number gain	not provided [RCV000849474]	Chr2:187445266..187627894 [GRCh37] Chr2:2q32.1	uncertain significance
GRCh37/hg19 2q24.2-34(chr2:163233162-211927188)x3	copy number gain	not provided [RCV001005349]	Chr2:163233162..211927188 [GRCh37] Chr2:2q24.2-34	pathogenic
GRCh37/hg19 2q32.1(chr2:186234826-188972311)x3	copy number gain	not provided [RCV000847709]	Chr2:186234826..188972311 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.407C>T (p.Thr136Ile)	single nucleotide variant	not specified [RCV004291356]	Chr2:186740396 [GRCh38] Chr2:187605123 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.605T>C (p.Leu202Ser)	single nucleotide variant	not specified [RCV004305029]	Chr2:186747131 [GRCh38] Chr2:187611858 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.748C>T (p.Pro250Ser)	single nucleotide variant	not provided [RCV000974935]	Chr2:186751157 [GRCh38] Chr2:187615884 [GRCh37] Chr2:2q32.1	benign
NM_177454.4(FAM171B):c.1563G>A (p.Ala521=)	single nucleotide variant	not provided [RCV000968549]	Chr2:186761905 [GRCh38] Chr2:187626632 [GRCh37] Chr2:2q32.1	benign
NM_177454.4(FAM171B):c.284G>A (p.Arg95His)	single nucleotide variant	not provided [RCV000957829]	Chr2:186740273 [GRCh38] Chr2:187605000 [GRCh37] Chr2:2q32.1	benign
NM_177454.4(FAM171B):c.2472C>T (p.Pro824=)	single nucleotide variant	not provided [RCV000956013]	Chr2:186762814 [GRCh38] Chr2:187627541 [GRCh37] Chr2:2q32.1	benign
GRCh37/hg19 2q31.1-32.3(chr2:174690039-195521582)x1	copy number loss	not provided [RCV001005359]	Chr2:174690039..195521582 [GRCh37] Chr2:2q31.1-32.3	pathogenic
GRCh37/hg19 2q31.2-37.3(chr2:178397959-243007457)x3	copy number gain	See cases [RCV001263052]	Chr2:178397959..243007457 [GRCh37] Chr2:2q31.2-37.3	pathogenic
GRCh37/hg19 2q32.1-34(chr2:185697659-213002074)	copy number loss	Chromosome 2q32-q33 deletion syndrome [RCV002280608]	Chr2:185697659..213002074 [GRCh37] Chr2:2q32.1-34	pathogenic
GRCh37/hg19 2q31.1-35(chr2:169829974-215521436)	copy number gain	not specified [RCV002053265]	Chr2:169829974..215521436 [GRCh37] Chr2:2q31.1-35	pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373)	copy number gain	Mosaic trisomy 2 [RCV002280628]	Chr2:1..243199373 [GRCh37] Chr2:2p25.3-q37.3	pathogenic
GRCh37/hg19 2q32.1(chr2:187466416-188487473)x3	copy number gain	not provided [RCV002475015]	Chr2:187466416..188487473 [GRCh37] Chr2:2q32.1	uncertain significance
GRCh37/hg19 2q32.1-33.1(chr2:187152754-199960525)x1	copy number loss	not provided [RCV002472632]	Chr2:187152754..199960525 [GRCh37] Chr2:2q32.1-33.1	pathogenic
NM_177454.4(FAM171B):c.1420C>A (p.Gln474Lys)	single nucleotide variant	not specified [RCV004222773]	Chr2:186761762 [GRCh38] Chr2:187626489 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1480C>A (p.Pro494Thr)	single nucleotide variant	not specified [RCV004231049]	Chr2:186761822 [GRCh38] Chr2:187626549 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1868A>T (p.Tyr623Phe)	single nucleotide variant	not specified [RCV004118708]	Chr2:186762210 [GRCh38] Chr2:187626937 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.181G>A (p.Glu61Lys)	single nucleotide variant	not specified [RCV004132234]	Chr2:186694354 [GRCh38] Chr2:187559081 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2387C>G (p.Thr796Ser)	single nucleotide variant	not specified [RCV004204640]	Chr2:186762729 [GRCh38] Chr2:187627456 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.937A>G (p.Asn313Asp)	single nucleotide variant	not specified [RCV004160256]	Chr2:186753974 [GRCh38] Chr2:187618701 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.886A>G (p.Met296Val)	single nucleotide variant	not specified [RCV004235170]	Chr2:186751295 [GRCh38] Chr2:187616022 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1736G>A (p.Arg579Gln)	single nucleotide variant	not specified [RCV004132588]	Chr2:186762078 [GRCh38] Chr2:187626805 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.794T>C (p.Leu265Pro)	single nucleotide variant	not specified [RCV004281193]	Chr2:186751203 [GRCh38] Chr2:187615930 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2459G>A (p.Arg820His)	single nucleotide variant	not specified [RCV004330820]	Chr2:186762801 [GRCh38] Chr2:187627528 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1463A>G (p.Asn488Ser)	single nucleotide variant	not specified [RCV004248404]	Chr2:186761805 [GRCh38] Chr2:187626532 [GRCh37] Chr2:2q32.1	likely benign
NM_177454.4(FAM171B):c.871G>T (p.Ala291Ser)	single nucleotide variant	not specified [RCV004259033]	Chr2:186751280 [GRCh38] Chr2:187616007 [GRCh37] Chr2:2q32.1	uncertain significance
GRCh37/hg19 2q32.1-36.1(chr2:186698504-223918111)x3	copy number gain	See cases [RCV003329558]	Chr2:186698504..223918111 [GRCh37] Chr2:2q32.1-36.1	pathogenic
NM_177454.4(FAM171B):c.2336C>T (p.Ser779Leu)	single nucleotide variant	not specified [RCV004334911]	Chr2:186762678 [GRCh38] Chr2:187627405 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1348A>G (p.Arg450Gly)	single nucleotide variant	not specified [RCV004351178]	Chr2:186761690 [GRCh38] Chr2:187626417 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1705G>A (p.Val569Ile)	single nucleotide variant	not specified [RCV004342065]	Chr2:186762047 [GRCh38] Chr2:187626774 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.796A>C (p.Lys266Gln)	single nucleotide variant	not specified [RCV004356323]	Chr2:186751205 [GRCh38] Chr2:187615932 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.52G>T (p.Val18Leu)	single nucleotide variant	not specified [RCV004338260]	Chr2:186694225 [GRCh38] Chr2:187558952 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1657C>A (p.Gln553Lys)	single nucleotide variant	not specified [RCV004380979]	Chr2:186761999 [GRCh38] Chr2:187626726 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.827C>T (p.Pro276Leu)	single nucleotide variant	not specified [RCV004380985]	Chr2:186751236 [GRCh38] Chr2:187615963 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.199A>G (p.Thr67Ala)	single nucleotide variant	not specified [RCV004380980]	Chr2:186694372 [GRCh38] Chr2:187559099 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.239T>C (p.Val80Ala)	single nucleotide variant	not specified [RCV004380981]	Chr2:186740228 [GRCh38] Chr2:187604955 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.811A>G (p.Ile271Val)	single nucleotide variant	not specified [RCV004380984]	Chr2:186751220 [GRCh38] Chr2:187615947 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2408C>A (p.Pro803Gln)	single nucleotide variant	not specified [RCV004380982]	Chr2:186762750 [GRCh38] Chr2:187627477 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1004G>A (p.Gly335Glu)	single nucleotide variant	not specified [RCV004380978]	Chr2:186754041 [GRCh38] Chr2:187618768 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.863G>A (p.Arg288His)	single nucleotide variant	not specified [RCV004625375]	Chr2:186751272 [GRCh38] Chr2:187615999 [GRCh37] Chr2:2q32.1	likely benign
NM_177454.4(FAM171B):c.1145G>A (p.Cys382Tyr)	single nucleotide variant	not specified [RCV004625376]	Chr2:186761487 [GRCh38] Chr2:187626214 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.640G>A (p.Val214Ile)	single nucleotide variant	not specified [RCV004625377]	Chr2:186747166 [GRCh38] Chr2:187611893 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2072A>C (p.Asp691Ala)	single nucleotide variant	not specified [RCV004625378]	Chr2:186762414 [GRCh38] Chr2:187627141 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.733A>G (p.Asn245Asp)	single nucleotide variant	not specified [RCV004625379]	Chr2:186751142 [GRCh38] Chr2:187615869 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1769C>T (p.Pro590Leu)	single nucleotide variant	not specified [RCV004625380]	Chr2:186762111 [GRCh38] Chr2:187626838 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.22G>T (p.Val8Phe)	single nucleotide variant	not specified [RCV004625381]	Chr2:186694195 [GRCh38] Chr2:187558922 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2254G>A (p.Val752Ile)	single nucleotide variant	not specified [RCV004920997]	Chr2:186762596 [GRCh38] Chr2:187627323 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1151C>G (p.Thr384Ser)	single nucleotide variant	not specified [RCV004920998]	Chr2:186761493 [GRCh38] Chr2:187626220 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2302A>G (p.Ser768Gly)	single nucleotide variant	not specified [RCV004921000]	Chr2:186762644 [GRCh38] Chr2:187627371 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.695A>G (p.His232Arg)	single nucleotide variant	not specified [RCV004921001]	Chr2:186747221 [GRCh38] Chr2:187611948 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.985A>G (p.Ile329Val)	single nucleotide variant	not specified [RCV004921002]	Chr2:186754022 [GRCh38] Chr2:187618749 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1567G>A (p.Gly523Arg)	single nucleotide variant	not specified [RCV004921003]	Chr2:186761909 [GRCh38] Chr2:187626636 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.1718T>C (p.Leu573Ser)	single nucleotide variant	not specified [RCV004921004]	Chr2:186762060 [GRCh38] Chr2:187626787 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2147C>T (p.Ser716Leu)	single nucleotide variant	not specified [RCV004921005]	Chr2:186762489 [GRCh38] Chr2:187627216 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.2192A>G (p.His731Arg)	single nucleotide variant	not specified [RCV004921006]	Chr2:186762534 [GRCh38] Chr2:187627261 [GRCh37] Chr2:2q32.1	uncertain significance
NM_177454.4(FAM171B):c.100C>T (p.Leu34Phe)	single nucleotide variant	not specified [RCV004920996]	Chr2:186694273 [GRCh38] Chr2:187559000 [GRCh37] Chr2:2q32.1	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	1056
Count of miRNA genes:	617
Interacting mature miRNAs:	721
Transcripts:	ENST00000304698
Prediction methods:	Miranda, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
407056965	GWAS705941_H	blood protein measurement QTL GWAS705941 (human)		3e-13	blood protein amount (VT:0005416)	blood protein measurement (CMO:0000028)	2	186736912	186736913	Human

SHGC-85093

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	2	187,578,277 - 187,578,548	UniSTS	GRCh37
Build 36	2	187,286,522 - 187,286,793	RGD	NCBI36
Celera	2	181,173,894 - 181,174,165	RGD
Cytogenetic Map	2	q32.1	UniSTS
HuRef	2	179,438,147 - 179,438,418	UniSTS

WI-17454

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	2	187,561,011 - 187,561,143	UniSTS	GRCh37
Build 36	2	187,269,256 - 187,269,388	RGD	NCBI36
Celera	2	181,156,636 - 181,156,768	RGD
Cytogenetic Map	2	q32.1	UniSTS
HuRef	2	179,420,876 - 179,421,008	UniSTS
GeneMap99-GB4 RH Map	2	590.19	UniSTS
Whitehead-RH Map	2	918.4	UniSTS

D2S2028

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	2	187,623,516 - 187,623,719	UniSTS	GRCh37
Build 36	2	187,331,761 - 187,331,964	RGD	NCBI36
Celera	2	181,219,141 - 181,219,344	RGD
Cytogenetic Map	2	q32.1	UniSTS
HuRef	2	179,483,388 - 179,483,591	UniSTS
Whitehead-YAC Contig Map	2		UniSTS

WI-11078

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	2	187,630,456 - 187,630,630	UniSTS	GRCh37
Build 36	2	187,338,701 - 187,338,875	RGD	NCBI36
Celera	2	181,226,080 - 181,226,254	RGD
Cytogenetic Map	2	q32.1	UniSTS
HuRef	2	179,490,326 - 179,490,500	UniSTS
GeneMap99-GB4 RH Map	2	591.54	UniSTS
Whitehead-RH Map	2	919.8	UniSTS

D2S2500

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	2	187,604,970 - 187,605,151	UniSTS	GRCh37
Build 36	2	187,313,215 - 187,313,396	RGD	NCBI36
Celera	2	181,200,595 - 181,200,776	RGD
Cytogenetic Map	2	q32.1	UniSTS
HuRef	2	179,464,842 - 179,465,023	UniSTS
GeneMap99-GB4 RH Map	2	590.19	UniSTS
Whitehead-RH Map	2	917.2	UniSTS
Whitehead-YAC Contig Map	2		UniSTS

D2S225

Human Assembly	Chr	Position (strand)	Source	JBrowse
Cytogenetic Map	2	q32.1	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system
1204	2424	2788	2236	4961	1717	2337	4	615	1814	457	2268	7145	6328	51	3726	845	1729	1612	172


RefSeq Transcripts	NM_177454	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB075826	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC017101	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF361495	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK091423	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK094578	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK095604	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK289737	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL834264	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC036478	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC060872	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471058	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068276	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000304698 ⟹ ENSP00000304108

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	2	186,694,060 - 186,765,959 (+)	Ensembl

Ensembl Acc Id:

ENST00000612606 ⟹ ENSP00000478477

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	2	186,694,080 - 186,751,257 (+)	Ensembl

RefSeq Acc Id:

NM_177454 ⟹ NP_803237

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	2	186,694,060 - 186,765,959 (+)	NCBI
GRCh37	2	187,558,789 - 187,630,686 (+)	NCBI
Build 36	2	187,267,034 - 187,336,759 (+)	NCBI Archive
Celera	2	181,154,411 - 181,224,139 (+)	RGD
HuRef	2	179,418,653 - 179,488,386 (+)	RGD
CHM1_1	2	187,564,785 - 187,634,506 (+)	NCBI
T2T-CHM13v2.0	2	187,183,195 - 187,255,094 (+)	NCBI

Sequence:

show sequence

GCAGATTGCGCGAGGGGGAGCGAGCGAGCGGGCGCTGCCAGGAGCCCGCAGCCCTGGCGCCCGCCGCCGCCCGGAGCCCCGCAATATGCCGCCGCGGCCCTCTGGCTCTAGGCCATGGCGAGGCTCTG
CCGGCGTGTCCCCTGCACCCTGCTTCTCGGCCTGGCCGTGGTGCTGCTGAAAGCGCGGCTGGTCCCCGCGGCCGCCAGAGCGGAACTCAGCCGCTCCGACCTCAGCCTCATCCAACAGCAGCAGCAGC
AGCAGCAACAACAACAACAACAGCAAAAGCAGCTGGAGGAGGCTGAGGAGGAGAGGACAGAGGTGCCTGGGGCAACCTCCACCTTGACGGTTCCAGTGTCTGTATTTATGTTGAAAGTCCAGGTGAAT
GACATCATCAGTCGTCAGTACCTGAGCCAAGCAGTTGTAGAAGTGTTTGTAAACTACACGAAGACAAATTCCACAGTAACTAAAAGCAATGGAGCAGTGCTGATAAAAGTACCCTACAAATTAGGACT
TAGTTTAACTATTATTGCTTACAAAGATGGCTACGTGTTGACCCCTCTGCCTTGGAAAACCAGAAGAATGCCAATATATTCATCAGTTACACTTTCACTGTTCCCGCAAAGCCAAGCAAATATATGGC
TATTTGAAGACACTGTTTTAATTACTGGAAAATTAGCTGATGCCAAGTCTCAACCAAGTGTTCAGTTTTCAAAAGCCTTAATTAAACTTCCTGACAACCATCATATTAGCAACGTTACTGGCTATCTT
ACAGTTCTACAACAGTTTTTGAAAGTGGACAATTTTCTGCATACAACTGGAATTACTCTCAATAAACCAGGTTTTGAAAACATTGAATTGACTCCTCTTGCTGCAATATGTGTGAAAATATATTCTGG
AGGAAAAGAACTAAAGGTCAATGGCTCTATTCAAGTTTCTCTTCCTCTTCTACGTCTGAATGATATAAGTGCAGGGGATCGCATACCTGCTTGGACATTTGATATGAACACAGGTGCTTGGGTAAATC
ATGGTCGGGGAATGGTCAAGGAACATAACAATCATTTAATCTGGACATATGATGCACCACATTTGGGGTACTGGATAGCAGCTCCACTTCCAGGAACTAGAGGTTCAGGTATAAATGAAGATTCCAAG
GACATAACTGCCTACCACACAGTGTTTCTTACAGCCATATTAGGAGGAACAATAGTCATTGTCATTGGATTTTTTGCTGTACTACTTTGTTATTGCAGGGACAAGTGTGGTACTCCACAGAAAAGAGA
AAGAAATATCACTAAACTTGAGGTCCTCAAGAGAGACCAGACAACTTCAACAACACACATAAATCATATCAGTACAGTTAAAGTTGCATTAAAAGCTGAGGACAAGTCGCAGTTATTCAATGCCAAAA
ACTCCTCATATAGTCCTCAGAAAAAGGAACCATCAAAGGCAGAAACAGAAGAAAGAGTTTCCATGGTAAAAACTCGGGACGATTTTAAAATCTACAATGAAGATGTTTCATTTCTATCAGTCAATCAA
AATAATTACTCAAGAAACCCAACACAGTCTTTGGAGCCCAATGTAGGGTCCAAACAACCTAAACATATTAACAACAATCTATCTTCATCTCTAGGTGATGCTCAAGATGAAAAGAGGTATCTCACAGG
TAATGAGGAGGCGTATGGGCGTTCCCATATTCCTGAACAGCTTATGCATATTTACAGCCAACCCATTGCCATCCTTCAAACATCTGACCTTTTCTCCACACCGGAACAATTACATACTGCTAAGTCAG
CTACTTTGCCAAGAAAGGGACAGTTAGTCTATGGCCAATTGATGGAACCAGTAAATCGAGAGAACTTTACGCAGACCTTGCCCAAAATGCCAATTCATTCTCATGCACAGCCCCCAGATGCCAGGGAA
GAGGATATCATACTTGAAGGTCAACAGAGCCTGCCATCCCAGGCTTCAGATTGGAGCCGATACTCAAGCAGCTTACTGGAATCCGTCTCTGTTCCTGGAACACTAAATGAGGCTGTTGTAATGACTCC
ATTTTCATCGGAACTTCAAGGAATTTCAGAACAGACCCTCCTGGAGCTGTCCAAAGGAAAGCCCTCCCCGCATCCCAGAGCCTGGTTTGTGTCTCTTGATGGAAAGCCAGTTGCACAAGTGAGGCACT
CCTTTATAGACCTGAAAAAGGGCAAGAGAACCCAGAGCAATGACACCAGTCTGGACTCTGGGGTGGACATGAATGAGCTTCACTCAAGTAGAAAGCTCGAGAGGGAGAAAACATTCATCAAAAGCATG
CATCAGCCCAAGATCCTTTACTTAGAAGATTTAGACCTAAGCAGCAGTGAGAGTGGAACCACCGTCTGTTCCCCTGAGGACCCAGCTTTAAGGCACATCCTAGATGGAGGGAGTGGAGTGATCATGGA
GCACCCTGGAGAAGAGTCGCCAGGAAGGAAAAGCACTGTTGAAGATTTTGAAGCTAATACATCCCCCACTAAAAGAAGGGGCAGACCACCACTAGCCAAAAGAGATAGCAAGACTAACATCTGGAAGA
AGCGAGAGGAACGCCCACTGATTCCCATAAATTAACTCCAATGGGGATTGTGTGTCTGCTGTCTCGTGCTGTTTATTCTTGCTTCTTGTTGTAAATTGCAGTACGAACTTAAGAAAATGAGACTGAGC
AATCTCATGGTTCTTGGACATGTCTCAAGCAGAGTAAATGGTAATTCAGTAATCAGAGAGAAAGATACCAAGGAATGCTTTTTCTGGCCTATTCATTTATTTTTGGGTGATGAATTTACAGTATCTAA
GTTTTCAAAATGTAAAATAGCTTCAAGATGTTAGTTATCTGAAAATGTTGCTCAGCCAGCCAGTTTGGCCTTGACTCTCTTAAGAATAACAGTGAAATATATACTCCTCAAGTTGCCTCCAAAAATGT
TGCCTCTACCATGGTGACTACCCCATGGAACATTTAGAAACAAAACTGACTTCAGGCATCATATTATTTTAAATGTTACTATTACGTCTTCTTCTGCCTATACTTAAAAATAACTTGATAAATGACTT
GGACTGATGTTACTCTGGAGTTATCACAAAGAAAATGTTGTTTGGTCTTTAAAGAGCATGTGTATTGTATCATCCCAAACGTAAATCCTACATTTATATAAGATGGGCAAGAAGCTACTTGGTCATTA
GAGAGGGAGACACCAGCTCTTTGGTTGTTTTTGGATATAACTTTACAAAATAAGTAAGATGTTAATTTAGAAATTTGAGAAATTAATGCTCTAATACTGAGTTTTTATTTAAAAATTATTTTTTCTTC
CCCTCAACAATGAAGCAAGCTTAGCTGTCAAGGGAAACTTTTTACAAATCTGAAAAAAACAATCTATGACTTTGGTTTAAGGCTCACTGATACTTTTAGGCTAAATTGGTTTTAATATATTTCTTCTA
TTCTAAAAACCTGAACTCAGTCACTTAAAGGCTATGAAATTTAAAAAAAAAGTCGATGTGAAAGTTTCTTTTGAACACTAAAATAAAATATGTGCAGATAAAATATACATTGATTTGTTTTTCTTAAA
TGTTGATGAGAAGAAAAAGAGATGCCATTTTCCTGAGGCTCAAAAATACCTTCAGGATAGTTGTATATCCAGTTATTGATTTTCTTAAAAGATGTGTAAGGAAAACAGTTTCAATTTCAGGGGAAAAG
TAAAAGTTTTTCCCTAAGTCACTTAAAGCCTTTGCAACTTCTTTTTTCAGTTTTGTAAGTAATATATCTATGTTCTTTTCATTATAGCAAGCATTCAATGTGAACAACTTTTTAATTAACTCTGAATT
ACCATTCATACATCCTAAAAATAAAAGCTCGTTATTCATTAAAATCAACTGATCCCATTTTTCTTAAAATTTCCCTGAAGGCAAATGTCTGAAGCACCTTTCCCTTGTGGGGGTAAAAATCCTAAATT
GCTTTATTTTTCATTCCCTCCTATTCAACATGGGAGCAGCATAGAGACCCAAACCATGTAAACAAGTTCAGTGAACCAAAACAGCCACATTAGCTTCAGTAAAATTATAGCTAGATGTGCAATTTTTT
CCTCCAACTTCTAACGTGTCAAATAACCTTCCTACTGTTCTGTGTTAACTGAAAGAACATAAAGACCCTAGGCAAATATTTGCTATATATTACCCCAATCCATAGAAGAAATAATGTTTTGGGTAATA
CCTAGGCTTCCTTTTTTTTTTTTTTTTTTTTTTTTTAGTGATAAGGCTCATAACAATTAATTAGAGAAGGCTTCTTATTGGTCTTACACAGAAAGATACATCAAAAGCAGCATGACTCAAAATGATTT
GGAAAAGGTTAAAGTTAGTGCTCTGCTGAAGTGCCTTTGATATAGACTTGCATTATTAGAAGGATATAACATCTTTTTTAAGTGTGCATTTTCTTTCAGTTAACCAAATTAAACAGATGTGCAGTTTT
ATTAAAAATATAGACCTAGTGTTTCATGTTGGAACAATAAATATTGCATGTGAGTAGTATTTCTTGTTTTTTGAATACAGTATATATTGATAAATTGTTTATGTTGGAATGAAGTTAGAAACTATATA
GCAAAACATTATATTTTAAGTGTTTATTTTTCCCACCTTTAAATAAAAATGTTTCATCTCAGCTTGGTAATGAAATACACATATTGGTATAAGGGTATACCATTCAGGTATGCCACTTATTTTATTCA
TTTTTGTGTAAGGGAAATGAGATGATGTATCCCAAGGGCTTTTCTAGAACTACTTGTTTGCTTTCAGAATAAAACCTTATTATTTTTTACACTGCACATGCTGTTCTCAATTGGTAATTATAGGCAAT
TTATCTTTTCTAATGATCAAAAGAGTGTGACTTCTCATTTGTGAGTAGTTCACAAATTTCCTGTTAAAAAGCTGAAACCATCTACTTTTTCTTAACCCAAGTGATAATAAACAATATTCACAACTTTC
TTAAATTTTTAAATTGAAAACCAAGGTTTTTTCAAATATAAACCTAGATGATTTTGGTCACAAATTGTTAACATTTGTCGATCCTTTGTATATACTTTGGATATATATTAAAGGCAAAACTATCTCTT
GACTAACTGATGGATTCATTTACTAAAGCACAGCTGTATGTATTTTTGAATACATATTATGATCTTGAGACTTTATAAATCAATTTTTATGACTTTATGCAGTTGTATAGGGATTATGCCCTTTCAGT
TCTATAGGGATTATGCCCTTTTATAATACATAATATACCACAGAGATTACAAATGTTGAGGAATGAAAGCACTTCTTTGCTTTGGCAATCATTTTCAGACCACTATGTGTTTGAATCCTCTGGTATCA
ATACGTATTATAGGGTTTTAGAGATCTGTGGGTCAAATGATGTCCCTCAAAACTTCCTAAAAAGGTGAAGCTCAAAGTCACACATTCTTATAAGGCGCATGAGTTTCTCATTTTCCCATGTACGAGCA
TTGTAAAGGAATTCAGCTGTATTAATTTCTATTTCAGATCTAGAATTGACATTTTGCCTTCTTGTTTCCAGGTGTTTCTATTTTTTGTATTCTTTCAGAGAAATCTCATATTTCGGTGTATTTATTGC
TGTTACTACTATATTTACTGCTGAAAACTGTAACAACCTGAAGATTTGTAAAATGTTAAACATAGTTCATTAAAAATAATAAAATAAATCTAAAATGTA

hide sequence


Protein RefSeqs	NP_803237	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH36478	(Get FASTA)	NCBI Sequence Viewer
	AAH60872	(Get FASTA)	NCBI Sequence Viewer
	AAL57220	(Get FASTA)	NCBI Sequence Viewer
	AAY24258	(Get FASTA)	NCBI Sequence Viewer
	BAB85532	(Get FASTA)	NCBI Sequence Viewer
	BAC03660	(Get FASTA)	NCBI Sequence Viewer
	BAC04380	(Get FASTA)	NCBI Sequence Viewer
	BAC04586	(Get FASTA)	NCBI Sequence Viewer
	BAF82426	(Get FASTA)	NCBI Sequence Viewer
	CAD38939	(Get FASTA)	NCBI Sequence Viewer
	EAX10930	(Get FASTA)	NCBI Sequence Viewer
	EAX10931	(Get FASTA)	NCBI Sequence Viewer
	EAX10932	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000304108
	ENSP00000304108.5
GenBank Protein	Q6P995	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_803237 ⟸ NM_177454
- Peptide Label:	precursor
- UniProtKB:	Q8TF55 (UniProtKB/Swiss-Prot), Q8NB81 (UniProtKB/Swiss-Prot), Q8N970 (UniProtKB/Swiss-Prot), Q8N3K1 (UniProtKB/Swiss-Prot), Q8N1Y4 (UniProtKB/Swiss-Prot), Q53SK3 (UniProtKB/Swiss-Prot), Q8WYR8 (UniProtKB/Swiss-Prot), Q6P995 (UniProtKB/Swiss-Prot), A8K122 (UniProtKB/TrEMBL)
- Sequence:	show sequence MARLCRRVPCTLLLGLAVVLLKARLVPAAARAELSRSDLSLIQQQQQQQQQQQQQQKQLEEAEEERTEVPGATSTLTVPVSVFMLKVQVNDIISRQYLSQAVVEVFVNYTKTNSTVTKSNGAVLIKVP YKLGLSLTIIAYKDGYVLTPLPWKTRRMPIYSSVTLSLFPQSQANIWLFEDTVLITGKLADAKSQPSVQFSKALIKLPDNHHISNVTGYLTVLQQFLKVDNFLHTTGITLNKPGFENIELTPLAAICV KIYSGGKELKVNGSIQVSLPLLRLNDISAGDRIPAWTFDMNTGAWVNHGRGMVKEHNNHLIWTYDAPHLGYWIAAPLPGTRGSGINEDSKDITAYHTVFLTAILGGTIVIVIGFFAVLLCYCRDKCGT PQKRERNITKLEVLKRDQTTSTTHINHISTVKVALKAEDKSQLFNAKNSSYSPQKKEPSKAETEERVSMVKTRDDFKIYNEDVSFLSVNQNNYSRNPTQSLEPNVGSKQPKHINNNLSSSLGDAQDEK RYLTGNEEAYGRSHIPEQLMHIYSQPIAILQTSDLFSTPEQLHTAKSATLPRKGQLVYGQLMEPVNRENFTQTLPKMPIHSHAQPPDAREEDIILEGQQSLPSQASDWSRYSSSLLESVSVPGTLNEA VVMTPFSSELQGISEQTLLELSKGKPSPHPRAWFVSLDGKPVAQVRHSFIDLKKGKRTQSNDTSLDSGVDMNELHSSRKLEREKTFIKSMHQPKILYLEDLDLSSSESGTTVCSPEDPALRHILDGGS GVIMEHPGEESPGRKSTVEDFEANTSPTKRRGRPPLAKRDSKTNIWKKREERPLIPIN hide sequence

Ensembl Acc Id:

ENSP00000478477 ⟸ ENST00000612606

Ensembl Acc Id:

ENSP00000304108 ⟸ ENST00000304698

Protein Domains

FAM171 C-terminal FAM171 N-terminal

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q6P995-F1-model_v2	AlphaFold	Q6P995	1-826	view protein structure

RGD ID:

6862280

Promoter ID:

EPDNEW_H4305

Type:

initiation region

Name:

FAM171B_1

Description:

family with sequence similarity 171 member B

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	2	186,694,062 - 186,694,122	EPDNEW

RGD ID:

6797276

Promoter ID:

HG_KWN:36291

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

K562, Lymphoblastoid

Transcripts:

ENST00000272804, OTTHUMT00000334679, UC002UPR.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	2	187,266,806 - 187,267,306 (+)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	FAM171B	COSMIC
Ensembl Genes	ENSG00000144369	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000304698	ENTREZGENE
	ENST00000304698.10	UniProtKB/Swiss-Prot
GTEx	ENSG00000144369	GTEx
HGNC ID	HGNC:29412	ENTREZGENE
Human Proteome Map	FAM171B	Human Proteome Map
InterPro	FAM171_C	UniProtKB/Swiss-Prot
	FAM171_N	UniProtKB/Swiss-Prot
	Uncharacterised_FAM171	UniProtKB/Swiss-Prot
KEGG Report	hsa:165215	UniProtKB/Swiss-Prot
NCBI Gene	165215	ENTREZGENE
OMIM	620309	OMIM
PANTHER	PROTEIN FAM171B	UniProtKB/Swiss-Prot
	PTHR31626	UniProtKB/Swiss-Prot
Pfam	FAM171A1-2-B_C	UniProtKB/Swiss-Prot
	UPF0560	UniProtKB/Swiss-Prot
PharmGKB	PA162387220	PharmGKB
UniProt	A8K122	ENTREZGENE, UniProtKB/TrEMBL
	B3LEU9_HUMAN	UniProtKB/TrEMBL
	F171B_HUMAN	UniProtKB/Swiss-Prot
	Q53SK3	ENTREZGENE
	Q6P995	ENTREZGENE
	Q8N1Y4	ENTREZGENE
	Q8N3K1	ENTREZGENE
	Q8N970	ENTREZGENE
	Q8NB81	ENTREZGENE
	Q8TF55	ENTREZGENE
	Q8WYR8	ENTREZGENE
UniProt Secondary	Q53SK3	UniProtKB/Swiss-Prot
	Q8N1Y4	UniProtKB/Swiss-Prot
	Q8N3K1	UniProtKB/Swiss-Prot
	Q8N970	UniProtKB/Swiss-Prot
	Q8NB81	UniProtKB/Swiss-Prot
	Q8TF55	UniProtKB/Swiss-Prot
	Q8WYR8	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2015-11-24	FAM171B	family with sequence similarity 171 member B		family with sequence similarity 171, member B	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message

Imported Disease Annotations - ClinVar